| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 252.76B | 243.38B | 234.74B | 227.42B | 211.59B |
| Gross Profit | 90.13B | 84.51B | 79.59B | 76.03B | 76.13B |
| EBITDA | 28.87B | 23.41B | 21.08B | 18.99B | 22.27B |
| Net Income | 15.07B | 11.09B | 9.50B | 8.42B | 10.90B |
Balance Sheet | |||||
| Total Assets | 285.15B | 276.91B | 268.68B | 279.88B | 276.84B |
| Cash, Cash Equivalents and Short-Term Investments | 61.41B | 68.06B | 59.66B | 80.38B | 88.61B |
| Total Debt | 4.34B | 6.75B | 7.65B | 8.10B | 9.70B |
| Total Liabilities | 88.83B | 82.40B | 81.28B | 98.36B | 95.42B |
| Stockholders Equity | 196.32B | 194.51B | 187.40B | 181.52B | 181.41B |
Cash Flow | |||||
| Free Cash Flow | 10.42B | 13.71B | -14.61B | -1.64B | 12.52B |
| Operating Cash Flow | 25.41B | 23.36B | -1.31B | 6.60B | 19.68B |
| Investing Cash Flow | -12.54B | -8.46B | -11.67B | -5.39B | -3.09B |
| Financing Cash Flow | -19.52B | -6.51B | -7.73B | -9.45B | -2.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥187.69B | 12.48 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥478.60B | 13.15 | 8.51% | 2.25% | 2.19% | 23.96% | |
73 Outperform | ¥31.66B | 9.00 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥169.09B | 11.58 | ― | 4.91% | 3.03% | 16.46% | |
67 Neutral | ¥18.75B | 8.43 | ― | 3.46% | 4.11% | 3.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
43 Neutral | ¥7.99B | -5.49 | ― | 2.65% | 1.29% | -181.94% |